-
1
-
-
4344574336
-
Pharmacogenetics-five decades of therapeutic lessons from genetic diversity
-
Meyer UA. Pharmacogenetics-five decades of therapeutic lessons from genetic diversity. Nat Rev Genet 2004; 5: 669-676.
-
(2004)
Nat Rev Genet
, vol.5
, pp. 669-676
-
-
Meyer, U.A.1
-
2
-
-
25144456112
-
Effectiveness of antipsychotic drugs in patients with chronic schizophrenia
-
Lieberman JA, Stroup TS, McEvoy JP, Swartz MS, Rosenheck RA, Perkins DO et al. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med 2005; 353: 1209-1223.
-
(2005)
N Engl J Med
, vol.353
, pp. 1209-1223
-
-
Lieberman, J.A.1
Stroup, T.S.2
McEvoy, J.P.3
Swartz, M.S.4
Rosenheck, R.A.5
Perkins, D.O.6
-
3
-
-
43449101550
-
A preliminary attempt to personalize risperidone dosing using drug-drug interactions and genetics: Part i
-
de Leon J, Sandson NB, Cozza KL. A preliminary attempt to personalize risperidone dosing using drug-drug interactions and genetics: part I. Psychosomatics 2008; 49: 258-270.
-
(2008)
Psychosomatics
, vol.49
, pp. 258-270
-
-
De Leon, J.1
Sandson, N.B.2
Cozza, K.L.3
-
4
-
-
73949139615
-
A common variant in DRD3 gene is associated with risperidone-induced extrapyramidal symptoms
-
Gasso P, Mas S, Bernardo M, Alvarez S, Parellada E, Lafuente A. A common variant in DRD3 gene is associated with risperidone-induced extrapyramidal symptoms. Pharmacogenomics J 2009; 9: 404-410.
-
(2009)
Pharmacogenomics J
, vol.9
, pp. 404-410
-
-
Gasso, P.1
Mas, S.2
Bernardo, M.3
Alvarez, S.4
Parellada, E.5
Lafuente, A.6
-
5
-
-
2342652255
-
Effects of various factors on steady-state plasma concentrations of risperidone and 9-hydroxyrisperidone: Lack of impact of MDR-1 genotypes
-
Yasui-Furukori N, Mihara K, Takahata T, Suzuki A, Nakagami T, De Vries R et al. Effects of various factors on steady-state plasma concentrations of risperidone and 9-hydroxyrisperidone: lack of impact of MDR-1 genotypes. Br J Clin Pharmacol; 57: 569-575.
-
Br J Clin Pharmacol
, vol.57
, pp. 569-575
-
-
Yasui-Furukori, N.1
Mihara, K.2
Takahata, T.3
Suzuki, A.4
Nakagami, T.5
De Vries, R.6
-
6
-
-
44049109281
-
Allelic variation in ApoC3, ApoA5 and LPL genes and first and second generation antipsychotic effects on serum lipids in patients with schizophrenia
-
Smith RC, Segman RH, Golcer-Dubner T, Pavlov V, Lerer B. Allelic variation in ApoC3, ApoA5 and LPL genes and first and second generation antipsychotic effects on serum lipids in patients with schizophrenia. Pharmacogenomics J 2008; 8: 228-236.
-
(2008)
Pharmacogenomics J
, vol.8
, pp. 228-236
-
-
Smith, R.C.1
Segman, R.H.2
Golcer-Dubner, T.3
Pavlov, V.4
Lerer, B.5
-
7
-
-
33646683308
-
Risperidonerelated weight gain: Genetic and nongenetic predictors
-
Lane HY, Liu YC, Huang CL, Chang YC, Wu PL, Lu CT et al. Risperidonerelated weight gain: genetic and nongenetic predictors. J Clin Psychopharmacol 2006; 26: 128-134.
-
(2006)
J Clin Psychopharmacol
, vol.26
, pp. 128-134
-
-
Lane, H.Y.1
Liu, Y.C.2
Huang, C.L.3
Chang, Y.C.4
Wu, P.L.5
Lu, C.T.6
-
8
-
-
34447506214
-
The association between HTR2C gene polymorphisms and the metabolic syndrome in patients with schizophrenia
-
Mulder H, Franke B, van der-Beek van der AA, Arends J, Wilmink FW, Scheffer H et al. The association between HTR2C gene polymorphisms and the metabolic syndrome in patients with schizophrenia. J Clin Psychopharmacol 2007; 27: 338-343.
-
(2007)
J Clin Psychopharmacol
, vol.27
, pp. 338-343
-
-
Mulder, H.1
Franke, B.2
Van Der-Beek Van Der, A.A.3
Arends, J.4
Wilmink, F.W.5
Scheffer, H.6
-
9
-
-
33645944971
-
DRD2 promoter region variation as a predictor of sustained response to antipsychotic medication in first-episode schizophrenia patients
-
Lencz T, Robinson DG, Xu K, Ekholm J, Sevy S, Gunduz-Bruce H et al. DRD2 promoter region variation as a predictor of sustained response to antipsychotic medication in first-episode schizophrenia patients. Am J Psychiatry 2006; 163: 529-531.
-
(2006)
Am J Psychiatry
, vol.163
, pp. 529-531
-
-
Lencz, T.1
Robinson, D.G.2
Xu, K.3
Ekholm, J.4
Sevy, S.5
Gunduz-Bruce, H.6
-
10
-
-
70349706135
-
Candidate-gene association analysis of response to risperidone in African-American and white patients with schizophrenia
-
Fijal BA, Kinon BJ, Kapur S, Stauffer VL, Conley RR, Jamal HH et al. Candidate-gene association analysis of response to risperidone in African-American and white patients with schizophrenia. Pharmacogenomics J 2009; 9: 311-318.
-
(2009)
Pharmacogenomics J
, vol.9
, pp. 311-318
-
-
Fijal, B.A.1
Kinon, B.J.2
Kapur, S.3
Stauffer, V.L.4
Conley, R.R.5
Jamal, H.H.6
-
11
-
-
58149251983
-
Functional serotonin 1A receptor variant influences treatment response to atypical antipsychotics in schizophrenia
-
Mossner R, Schuhmacher A, Kuhn KU, Cvetanovska G, Rujescu D, Zill P et al. Functional serotonin 1A receptor variant influences treatment response to atypical antipsychotics in schizophrenia. Pharmacogenet Genomics 2009; 19: 91-94.
-
(2009)
Pharmacogenet Genomics
, vol.19
, pp. 91-94
-
-
Mossner, R.1
Schuhmacher, A.2
Kuhn, K.U.3
Cvetanovska, G.4
Rujescu, D.5
Zill, P.6
-
12
-
-
34247481499
-
Physiogenomic comparison of weight profiles of olanzapine-and risperidone-treated patients
-
Ruano G, Goethe JW, Caley C, Woolley S, Holford TR, Kocherla M et al. Physiogenomic comparison of weight profiles of olanzapine-and risperidone-treated patients. Mol Psychiatry 2007; 12: 474-482.
-
(2007)
Mol Psychiatry
, vol.12
, pp. 474-482
-
-
Ruano, G.1
Goethe, J.W.2
Caley, C.3
Woolley, S.4
Holford, T.R.5
Kocherla, M.6
-
13
-
-
0032421570
-
The Mini-International Neuropsychiatric Interview (MINI): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10
-
quiz-57
-
Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E et al. The Mini-International Neuropsychiatric Interview (MINI): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry; 59(Suppl 20): 22-33; quiz-57.
-
J Clin Psychiatry
, vol.59
, Issue.SUPPL. 20
, pp. 22-33
-
-
Sheehan, D.V.1
Lecrubier, Y.2
Sheehan, K.H.3
Amorim, P.4
Janavs, J.5
Weiller, E.6
-
14
-
-
0023244845
-
The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients
-
Lingjaerde O, Ahlfors UG, Bech P, Dencker SJ, Elgen K. The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients. Acta Psychiatr Scand Suppl 1987; 334: 1-100.
-
(1987)
Acta Psychiatr Scand Suppl
, vol.334
, pp. 1-100
-
-
Lingjaerde, O.1
Ahlfors, U.G.2
Bech, P.3
Dencker, S.J.4
Elgen, K.5
-
15
-
-
23444435523
-
Reliable low-density DNA array based on allele-specific probes for detection of 118 mutations causing familial hypercholesterolemia
-
Tejedor D, Castillo S, Mozas P, Jimenez E, Lopez M, Tejedor MT et al. Reliable low-density DNA array based on allele-specific probes for detection of 118 mutations causing familial hypercholesterolemia. Clin Chem 2005; 51: 1137-1144.
-
(2005)
Clin Chem
, vol.51
, pp. 1137-1144
-
-
Tejedor, D.1
Castillo, S.2
Mozas, P.3
Jimenez, E.4
Lopez, M.5
Tejedor, M.T.6
-
16
-
-
78649704941
-
Evaluating a newly developed pharmacogenetic array: Screening in a Spanish population
-
Almoguera B, Riveiro-Alvarez R, Gomez-Dominguez B, Lopez-Rodriguez R, Dorado P, Vaquero-Lorenzo C et al. Evaluating a newly developed pharmacogenetic array: screening in a Spanish population. Pharmacogenomics 2010; 11: 1619-1625.
-
(2010)
Pharmacogenomics
, vol.11
, pp. 1619-1625
-
-
Almoguera, B.1
Riveiro-Alvarez, R.2
Gomez-Dominguez, B.3
Lopez-Rodriguez, R.4
Dorado, P.5
Vaquero-Lorenzo, C.6
-
17
-
-
77949632773
-
Errors and reproducibility of DNA array-based detection of allelic variants in ADME genes: PHARMAchip
-
Cuyas E, Olano-Martin E, Khymenets O, Hernandez L, Jofre-Monseny L, Grandoso L et al. Errors and reproducibility of DNA array-based detection of allelic variants in ADME genes: PHARMAchip. Pharmacogenomics 2010; 11: 257-266.
-
(2010)
Pharmacogenomics
, vol.11
, pp. 257-266
-
-
Cuyas, E.1
Olano-Martin, E.2
Khymenets, O.3
Hernandez, L.4
Jofre-Monseny, L.5
Grandoso, L.6
-
18
-
-
77957265906
-
Effects of CYP2D6 genotype on the pharmacokinetics, pharmacodynamics, and safety of risperidone in healthy volunteers
-
Novalbos J, Lopez-Rodriguez R, Roman M, Gallego-Sandin S, Ochoa D, Abad-Santos F. Effects of CYP2D6 genotype on the pharmacokinetics, pharmacodynamics, and safety of risperidone in healthy volunteers. J Clin Psychopharmacol 2010; 30: 504-511.
-
(2010)
J Clin Psychopharmacol
, vol.30
, pp. 504-511
-
-
Novalbos, J.1
Lopez-Rodriguez, R.2
Roman, M.3
Gallego-Sandin, S.4
Ochoa, D.5
Abad-Santos, F.6
-
19
-
-
13844320650
-
The CYP2D6 poor metabolizer phenotype may be associated with risperidone adverse drug reactions and discontinuation
-
de Leon J, Susce MT, Pan RM, Fairchild M, Koch WH, Wedlund PJ. The CYP2D6 poor metabolizer phenotype may be associated with risperidone adverse drug reactions and discontinuation. J Clin Psychiatry 2005; 66: 15-27.
-
(2005)
J Clin Psychiatry
, vol.66
, pp. 15-27
-
-
De Leon, J.1
Susce, M.T.2
Pan, R.M.3
Fairchild, M.4
Koch, W.H.5
Wedlund, P.J.6
-
20
-
-
77953764539
-
Relationship between response to risperidone, plasma concentrations of risperidone and CYP3A4 polymorphisms in schizophrenia patients
-
Du J, Zhang A, Wang L, Xuan J, Yu L, Che R et al. Relationship between response to risperidone, plasma concentrations of risperidone and CYP3A4 polymorphisms in schizophrenia patients. J Psychopharmacol 2009; 24: 1115-1120.
-
(2009)
J Psychopharmacol
, vol.24
, pp. 1115-1120
-
-
Du, J.1
Zhang, A.2
Wang, L.3
Xuan, J.4
Yu, L.5
Che, R.6
-
21
-
-
50449094308
-
The influence of 5-HT(2C) and MDR1 genetic polymorphisms on antipsychotic-induced weight gain in female schizophrenic patients
-
Kuzman MR, Medved V, Bozina N, Hotujac L, Sain I, Bilusic H. The influence of 5-HT(2C) and MDR1 genetic polymorphisms on antipsychotic-induced weight gain in female schizophrenic patients. Psychiatry Res 2008; 160: 308-315.
-
(2008)
Psychiatry Res
, vol.160
, pp. 308-315
-
-
Kuzman, M.R.1
Medved, V.2
Bozina, N.3
Hotujac, L.4
Sain, I.5
Bilusic, H.6
-
22
-
-
33750454081
-
Polymorphisms of the ABCB1 gene are associated with the therapeutic response to risperidone in Chinese schizophrenia patients
-
Xing Q, Gao R, Li H, Feng G, Xu M, Duan S et al. Polymorphisms of the ABCB1 gene are associated with the therapeutic response to risperidone in Chinese schizophrenia patients. Pharmacogenomics 2006; 7: 987-993.
-
(2006)
Pharmacogenomics
, vol.7
, pp. 987-993
-
-
Xing, Q.1
Gao, R.2
Li, H.3
Feng, G.4
Xu, M.5
Duan, S.6
-
23
-
-
40549107457
-
An investigation of the alpha1A-adrenergic receptor gene and antipsychotic-induced side-effects
-
Saiz PA, Susce MT, Clark DA, Kerwin RW, Molero P, Arranz MJ et al. An investigation of the alpha1A-adrenergic receptor gene and antipsychotic-induced side-effects. Hum Psychopharmacol 2008; 23: 107-114.
-
(2008)
Hum Psychopharmacol
, vol.23
, pp. 107-114
-
-
Saiz, P.A.1
Susce, M.T.2
Clark, D.A.3
Kerwin, R.W.4
Molero, P.5
Arranz, M.J.6
-
24
-
-
77952672271
-
Genetic variants in the BDNF gene and therapeutic response to risperidone in schizophrenia patients: A pharmacogenetic study
-
Xu M, Li S, Xing Q, Gao R, Feng G, Lin Z et al. Genetic variants in the BDNF gene and therapeutic response to risperidone in schizophrenia patients: a pharmacogenetic study. Eur J Hum Genet 2010; 18: 707-712.
-
(2010)
Eur J Hum Genet
, vol.18
, pp. 707-712
-
-
Xu, M.1
Li, S.2
Xing, Q.3
Gao, R.4
Feng, G.5
Lin, Z.6
-
25
-
-
64549107574
-
Association studies of catechol-O-methyltransferase (COMT) gene with schizophrenia and response to antipsychotic treatment
-
Gupta M, Bhatnagar P, Grover S, Kaur H, Baghel R, Bhasin Y et al. Association studies of catechol-O-methyltransferase (COMT) gene with schizophrenia and response to antipsychotic treatment. Pharmacogenomics 2009; 10: 385-397.
-
(2009)
Pharmacogenomics
, vol.10
, pp. 385-397
-
-
Gupta, M.1
Bhatnagar, P.2
Grover, S.3
Kaur, H.4
Baghel, R.5
Bhasin, Y.6
-
26
-
-
55649099694
-
Variants of dopamine and serotonin candidate genes as predictors of response to risperidone treatment in first-episode schizophrenia
-
Ikeda M, Yamanouchi Y, Kinoshita Y, Kitajima T, Yoshimura R, Hashimoto S et al. Variants of dopamine and serotonin candidate genes as predictors of response to risperidone treatment in first-episode schizophrenia. Pharmacogenomics 2008; 9: 1437-1443.
-
(2008)
Pharmacogenomics
, vol.9
, pp. 1437-1443
-
-
Ikeda, M.1
Yamanouchi, Y.2
Kinoshita, Y.3
Kitajima, T.4
Yoshimura, R.5
Hashimoto, S.6
-
27
-
-
77957132192
-
Pharmacogenetics of risperidone therapy in autism: Association analysis of eight candidate genes with drug efficacy and adverse drug reactions
-
Correia CT, Almeida JP, Santos PE, Sequeira AF, Marques CE, Miguel TS et al. Pharmacogenetics of risperidone therapy in autism: association analysis of eight candidate genes with drug efficacy and adverse drug reactions. Pharmacogenomics J 2010; 10: 418-430.
-
(2010)
Pharmacogenomics J
, vol.10
, pp. 418-430
-
-
Correia, C.T.1
Almeida, J.P.2
Santos, P.E.3
Sequeira, A.F.4
Marques, C.E.5
Miguel, T.S.6
-
28
-
-
63149084646
-
Further evidence for association of the RGS2 gene with antipsychoticinduced parkinsonism: Protective role of a functional polymorphism in the 30-untranslated region
-
Greenbaum L, Smith RC, Rigbi A, Strous R, Teltsh O, Kanyas K et al. Further evidence for association of the RGS2 gene with antipsychoticinduced parkinsonism: protective role of a functional polymorphism in the 30-untranslated region. Pharmacogenomics J 2009; 9: 103-110.
-
(2009)
Pharmacogenomics J
, vol.9
, pp. 103-110
-
-
Greenbaum, L.1
Smith, R.C.2
Rigbi, A.3
Strous, R.4
Teltsh, O.5
Kanyas, K.6
-
29
-
-
38649086421
-
Could HTR2A T102C and DRD3 Ser9Gly predict clinical improvement in patients with acutely exacerbated schizophrenia? Results from treatment responses to risperidone in a naturalistic setting
-
Kim B, Choi EY, Kim CY, Song K, Joo YH. Could HTR2A T102C and DRD3 Ser9Gly predict clinical improvement in patients with acutely exacerbated schizophrenia? Results from treatment responses to risperidone in a naturalistic setting. Hum Psychopharmacol 2008; 23: 61-67.
-
(2008)
Hum Psychopharmacol
, vol.23
, pp. 61-67
-
-
Kim, B.1
Choi, E.Y.2
Kim, C.Y.3
Song, K.4
Joo, Y.H.5
-
30
-
-
73449118202
-
Serotonin transporter polymorphisms and early response to antipsychotic treatment in first episode of psychosis
-
Vazquez-Bourgon J, Arranz MJ, Mata I, Pelayo-Teran JM, Perez-Iglesias R, Medina-Gonzalez L et al. Serotonin transporter polymorphisms and early response to antipsychotic treatment in first episode of psychosis. Psychiatry Res 2010; 175: 189-194.
-
(2010)
Psychiatry Res
, vol.175
, pp. 189-194
-
-
Vazquez-Bourgon, J.1
Arranz, M.J.2
Mata, I.3
Pelayo-Teran, J.M.4
Perez-Iglesias, R.5
Medina-Gonzalez, L.6
-
31
-
-
38349132802
-
The CYP2D6 activity score: Translating genotype information into a qualitative measure of phenotype
-
Gaedigk A, Simon SD, Pearce RE, Bradford LD, Kennedy MJ, Leeder JS. The CYP2D6 activity score: translating genotype information into a qualitative measure of phenotype. Clin Pharmacol Ther 2008; 83: 234-242.
-
(2008)
Clin Pharmacol Ther
, vol.83
, pp. 234-242
-
-
Gaedigk, A.1
Simon, S.D.2
Pearce, R.E.3
Bradford, L.D.4
Kennedy, M.J.5
Leeder, J.S.6
-
32
-
-
0035120410
-
Atypical antipsychotics: New directions and new challenges in the treatment of schizophrenia
-
Kapur S, Remington G. Atypical antipsychotics: new directions and new challenges in the treatment of schizophrenia. Annu Rev Med 2001; 52: 503-517.
-
(2001)
Annu Rev Med
, vol.52
, pp. 503-517
-
-
Kapur, S.1
Remington, G.2
-
33
-
-
33745227236
-
Effects of atypical and typical antipsychotic treatments on sexual function in patients with schizophrenia: 12-month results from the Intercontinental Schizophrenia Outpatient Health Outcomes (IC-SOHO) study
-
Dossenbach M, Dyachkova Y, Pirildar S, Anders M, Khalil A, Araszkiewicz A et al. Effects of atypical and typical antipsychotic treatments on sexual function in patients with schizophrenia: 12-month results from the Intercontinental Schizophrenia Outpatient Health Outcomes (IC-SOHO) study. Eur Psychiatry 2006; 21: 251-258.
-
(2006)
Eur Psychiatry
, vol.21
, pp. 251-258
-
-
Dossenbach, M.1
Dyachkova, Y.2
Pirildar, S.3
Anders, M.4
Khalil, A.5
Araszkiewicz, A.6
-
34
-
-
68149171653
-
Sexual dysfunction in patients with schizophrenia treated with conventional antipsychotics or risperidone
-
Liu-Seifert H, Kinon BJ, Tennant CJ, Sniadecki J, Volavka J. Sexual dysfunction in patients with schizophrenia treated with conventional antipsychotics or risperidone. Neuropsychiatr Dis Treat 2009; 5: 47-54.
-
(2009)
Neuropsychiatr Dis Treat
, vol.5
, pp. 47-54
-
-
Liu-Seifert, H.1
Kinon, B.J.2
Tennant, C.J.3
Sniadecki, J.4
Volavka, J.5
-
35
-
-
0036313928
-
Influence of the beta2-adrenergic receptor Arg16Gly polymorphism on longitudinal changes in obesity from childhood through young adulthood in a biracial cohort: The Bogalusa Heart Study
-
Ellsworth DL, Coady SA, Chen W, Srinivasan SR, Elkasabany A, Gustat J et al. Influence of the beta2-adrenergic receptor Arg16Gly polymorphism on longitudinal changes in obesity from childhood through young adulthood in a biracial cohort: the Bogalusa Heart Study. Int J Obes Relat Metab Disord 2002; 26: 928-937.
-
(2002)
Int J Obes Relat Metab Disord
, vol.26
, pp. 928-937
-
-
Ellsworth, D.L.1
Coady, S.A.2
Chen, W.3
Srinivasan, S.R.4
Elkasabany, A.5
Gustat, J.6
-
36
-
-
67649858775
-
Diverse evolutionary histories for beta-adrenoreceptor genes in humans
-
Cagliani R, Fumagalli M, Pozzoli U, Riva S, Comi GP, Torri F et al. Diverse evolutionary histories for beta-adrenoreceptor genes in humans. Am J Hum Genet 2009; 85: 64-75.
-
(2009)
Am J Hum Genet
, vol.85
, pp. 64-75
-
-
Cagliani, R.1
Fumagalli, M.2
Pozzoli, U.3
Riva, S.4
Comi, G.P.5
Torri, F.6
-
37
-
-
77949756362
-
Genome-wide association studies in pharmacogenomics
-
Daly AK. Genome-wide association studies in pharmacogenomics. Nat Rev Genet 2010; 11: 241-246.
-
(2010)
Nat Rev Genet
, vol.11
, pp. 241-246
-
-
Daly, A.K.1
-
38
-
-
0347363538
-
Role of dopamine D3 receptor (DRD3) and dopamine transporter (DAT) polymorphism in cognitive dysfunctions and therapeutic response to atypical antipsychotics in patients with schizophrenia
-
Szekeres G, Keri S, Juhasz A, Rimanoczy A, Szendi I, Czimmer C et al. Role of dopamine D3 receptor (DRD3) and dopamine transporter (DAT) polymorphism in cognitive dysfunctions and therapeutic response to atypical antipsychotics in patients with schizophrenia. Am J Med Genet B Neuropsychiatr Genet 2004; 124B: 1-5.
-
(2004)
Am J Med Genet B Neuropsychiatr Genet
, vol.124 B
, pp. 1-5
-
-
Szekeres, G.1
Keri, S.2
Juhasz, A.3
Rimanoczy, A.4
Szendi, I.5
Czimmer, C.6
-
39
-
-
36949028092
-
Effects of the dopamine D3 receptor (DRD3) gene polymorphisms on risperidone response: A pharmacogenetic study
-
Xuan J, Zhao X, He G, Yu L, Wang L, Tang W et al. Effects of the dopamine D3 receptor (DRD3) gene polymorphisms on risperidone response: a pharmacogenetic study. Neuropsychopharmacology 2008; 33: 305-311.
-
(2008)
Neuropsychopharmacology
, vol.33
, pp. 305-311
-
-
Xuan, J.1
Zhao, X.2
He, G.3
Yu, L.4
Wang, L.5
Tang, W.6
-
40
-
-
77958141851
-
Underlying brain mechanisms that regulate sleep-wakefulness cycles
-
Gvilia I. Underlying brain mechanisms that regulate sleep-wakefulness cycles. International review of neurobiology 2010; 93: 1-21.
-
(2010)
International Review of Neurobiology
, vol.93
, pp. 1-21
-
-
Gvilia, I.1
-
41
-
-
33846820225
-
Serotonin and dopamine receptor gene polymorphisms and the risk of extrapyramidal side effects in perphenazine-treated schizophrenic patients
-
Gunes A, Scordo MG, Jaanson P, Dahl ML. Serotonin and dopamine receptor gene polymorphisms and the risk of extrapyramidal side effects in perphenazine-treated schizophrenic patients. Psychopharmacology 2007; 190: 479-484.
-
(2007)
Psychopharmacology
, vol.190
, pp. 479-484
-
-
Gunes, A.1
Scordo, M.G.2
Jaanson, P.3
Dahl, M.L.4
-
42
-
-
0031594675
-
D3 dopamine receptor mRNA is widely expressed in the human brain
-
Suzuki M, Hurd YL, Sokoloff P, Schwartz JC, Sedvall G. D3 dopamine receptor mRNA is widely expressed in the human brain. Brain Res 1998; 779: 58-74.
-
(1998)
Brain Res
, vol.779
, pp. 58-74
-
-
Suzuki, M.1
Hurd, Y.L.2
Sokoloff, P.3
Schwartz, J.C.4
Sedvall, G.5
-
43
-
-
0029572353
-
Effects on locomotor activity after local application of D3 preferring compounds in discrete areas of the rat brain
-
Kling-Petersen T, Ljung E, Svensson K. Effects on locomotor activity after local application of D3 preferring compounds in discrete areas of the rat brain. J Neural Transm Gen Sect 1995; 102: 209-220.
-
(1995)
J Neural Transm Gen Sect
, vol.102
, pp. 209-220
-
-
Kling-Petersen, T.1
Ljung, E.2
Svensson, K.3
-
44
-
-
0030598907
-
Proposed schizophrenia-related gene polymorphism: Expression of the Ser9Gly mutant human dopamine D3 receptor with the Semliki Forest virus system
-
Lundstrom K, Turpin MP. Proposed schizophrenia-related gene polymorphism: expression of the Ser9Gly mutant human dopamine D3 receptor with the Semliki Forest virus system. Biochem Biophys Res Commun 1996; 225: 1068-1072.
-
(1996)
Biochem Biophys Res Commun
, vol.225
, pp. 1068-1072
-
-
Lundstrom, K.1
Turpin, M.P.2
|